Brought to you by:
TRANSCEND 36-month data “continue to demonstrate safe and effective performance” of SurVeil DCB
Peter Schneider (University of California San Francisco, San Francisco, USA) recently presented 36-month data from Surmodics’ TRANSCEND clinical trial at the VEITHsymposium 2023 (14–18 November, New York, USA). The TRANSCEND trial is a prospective, multicentre, single-blind randomised controlled trial to…
VAM abstract submissions window opens
VAM program chair Andres Schanzer, MD, makes a call for cutting-edge new science for next year’s meeting in Chicago. Researchers who want to present new science at the 2024 Vascular Annual Meeting (VAM) are encouraged to prepare their abstracts for…
Change: A driving force behind SVS advocacy initiatives
Change is a constant in life, and advocacy is no exception. The healthcare landscape is always evolving, and the SVS Advocacy Council is working to maintain a voice in the decision-making process. The council is committed to driving change that…
The pulmonary arterial tree—it is time we branch out
Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health System in Bay City, Michigan, urges vascular surgeons to “get out of their comfort zone” and become more involved in pulmonary embolism (PE) care. With more than 1 million cases…
Twelve-month first-in-human data from Xeltis’ aXess haemodialysis vascular conduit trial presented at VEITHsymposium 2023
Xeltis has announced “highly encouraging” 12-month results from its first-in-human (FIH) aXess vascular conduit trial. The data were presented by Frans Moll (University Medical Center Utrecht, Utrecht, The Netherlands) at this year’s VEITHsymposium (14–18 November, New York, USA). At 12…
Randomized trial set to elucidate value of image fusion technology for aortic repair
An ongoing UK National Institute for Health and Care Research (NIHR)-funded randomized controlled trial seeks to illuminate the value of an image fusion guidance technology for endovascular aortic repair. In a presentation on the trial at this year’s VEITHsymposium…
Impact of the CMS proposed rule on the QPP for 2024
This summer the center for medicare and Medicaid Services (CMS) published its annual Physician Fee Schedule and Proposed Rule for calendar year 2024, and on Nov. 2 the Final Rule was published. The proposed rule included several proposals within the…
Two-year SWING data ‘continue to show promise’ for sirolimus DCB in treating BTK disease
Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been presented at this year’s VEITHsymposium (Nov. 14–18) in New York City. The SWING trial is a…
Specialty representation at all levels of a healthcare organization is ‘increasingly important’ in value-based systems
A 14-year effort to achieve departmental status for vascular surgery at a large healthcare system in Southern California resulted in significant gains for the specialty within the organizational apparatus, according to an administrative case report on an effort finalized last…
NIH-funded research on the use of AI in vascular surgery: A decade in the making
Vascular surgeon-scientist Elsie Gyang Ross, MD, recently secured coveted funding through the National Institutes of Health (NIH) Research Project Grant Program (R01)—a rare feat for one so young having managed to achieve the career landmark before the age of 40.…